Form D · Biotechnology

Vivione Biosciences, LLC

Irving, TX · CIK 0001657008

Offering snapshot reported Nov 13, 2015 · SEC filing

Reported sold
$3.02M
Offering amount: $4.52M
Investors reported
10
Form D · investor count
Minimum accepted
$1M
Reported outside-investor minimum
First sale
Oct 30, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.51M$3.02MNov 12, 2015: $1,435,484.00Nov 12, 2015Nov 13, 2015: $3,020,168.00Nov 13, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,435,484 → $3,020,168

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 13, 2015Amendment$3,020,168$1,584,684vs Nov 12, 201510SEC filing
Nov 12, 2015Initial$1,435,484No comparison10SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-251079
Number of Units offered and sold were originally reported. Amendment filed to report dollar amount offered and sold.

Source: Form D, filed Nov 13, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Matthew Gombrich, M.D. Executive
James K. Hendren Director
Chester J. Jachimiec Director, Executive
Kevin D. Kuykendall Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
8600 Freeport Parkway Suite 110
Irving, TX, 75063